NTCOC
TEVA icon

Northern Trust Company of Connecticut’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Northern Trust Company of Connecticut’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$15.7M Sell
391,156
-52,972
-12% -$2.09M 0.1% 296
2013
Q3 		$16.8M Sell
444,128
-61,645
-12% -$2.4M 0.11% 261
2013
Q2 		$19.8M Buy
+505,773
New +$19.7M 0.13% 198

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Northern Trust Company of Connecticut's TEVA Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 12% in Q4 2013, selling an estimated $2.09M and leaving 391,156 shares worth $15.7M. The position accounts for 0.1% of the portfolio, ranked #296.

Northern Trust Company of Connecticut first reported a position in TEVA in Q2 2013 and has held it in 3 quarters since. The position peaked at $19.8M in Q2 2013. 728 funds tracked by Wall St. Rank hold TEVA as of Q4 2013.

  • Northern Trust Company of Connecticut held 391,156 shares of Teva Pharmaceutical Industries Limited worth $15.7M as of Q4 2013.
  • Northern Trust Company of Connecticut sold 52,972 Teva Pharmaceutical Industries Limited shares in Q4 2013, an estimated $2.09M.
  • Teva Pharmaceutical Industries Limited made up 0.1% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #296 holding.
  • Northern Trust Company of Connecticut first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's Teva Pharmaceutical Industries Limited position peaked at $19.8M in Q2 2013.
  • 728 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.